Dudediligence.

Verastem, Inc

VSTMNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Dec ’24$2.1MJun ’25$11.2MSep ’25$17.5MDec ’25$18.7MMar ’26$40.1MJun ’26
Net income, by quarter
−$24.0MSep ’24−$64.6MDec ’24−$52.1MMar ’25−$25.9MJun ’25−$98.5MSep ’25−$32.9MDec ’25−$36.6MMar ’26−$34.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.1M$2.6Mnone on file$10.0M$30.9M
Operating income−$61.4M−$72.9M−$92.1M−$115.0M−$170.1M
Net income−$71.2M−$73.8M−$87.4M−$130.6M−$209.5M
Operating cash flow−$53.5M−$63.7M−$86.5M−$104.8M−$137.5M
Free cash flow−$53.7Mnone on filenone on file−$104.8Mnone on file
Cash$21.3M$74.9M$77.9M$88.8M$205.0M
Debtnone on file$24.5M$40.1M$40.7Mnone on file
Shares outstanding185.3M16.7M25.3M44.8M77.7M